Diabetes, kidney failure and fibrosis
- Prosjektnummer
- 2014081
- Ansvarlig person
- Trond Jenssen
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Metabolic and Endocrine, Renal and Urogenital
- Forskningsaktivitet
- 4. Detection and Diagnosis, 5. Treatment Developement
Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro.
Food Nutr Res 2016;60():32615. Epub 2016 sep 23
PMID: 27667774
Serglycin in Quiescent and Proliferating Primary Endothelial Cells.
PLoS One 2015;10(12):e0145584. Epub 2015 des 22
PMID: 26694746
Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation.
Diabetes Res Clin Pract 2015 Jan;107(1):46-53. Epub 2014 okt 28
PMID: 25467621
Syndecan-4 is a major syndecan in primary human endothelial cells in vitro, modulated by inflammatory stimuli and involved in wound healing.
J Histochem Cytochem 2015 Apr;63(4):280-92. Epub 2015 jan 9
PMID: 25575567
Serglycin is part of the secretory repertoire of LPS-activated monocytes.
Immun Inflamm Dis 2015 Mar;3(1):23-31. Epub 2015 feb 11
PMID: 25866637
Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro.
Biochim Biophys Acta 2014 Aug;1840(8):2498-505. Epub 2014 feb 7
PMID: 24513305
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone.
Diabetologia 2014 Nov;57(11):2357-65. Epub 2014 aug 22
PMID: 25145544
An in vitro study of primary human endothelial cells
http://www.duo.uio.no/ masteroppgave 2015
Proteoglycans in inflammation, atherosclerosis, diabetic nephropathy and during physical activity with emphasis on serglycin
- Disputert:
- oktober 2015
- Hovedveileder:
- Svein Olav Kolset
- Harald Andre Hermansen Prosjektdeltaker
- Trine M. Reine Postdoktorstipendiat (finansiert av denne bevilgning)
- Trond Geir Jenssen Prosjektleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport